Literature DB >> 27401690

Nosocomial candidemia in patients admitted to medicine wards compared to other wards: a multicentre study.

Roberto Luzzati1, Maria Merelli2, Filippo Ansaldi3, Chiara Rosin4, Annamaria Azzini5, Silvia Cavinato6, Pierluigi Brugnaro7, Claudio Vedovelli8, Annamaria Cattelan6, Busetti Marina9, Giuseppe Gatti10, Ercole Concia5, Matteo Bassetti2.   

Abstract

PURPOSE: Risk factors for nosocomial candidemia, severity of sepsis, treatment, and outcome were compared between patients admitted to medicine wards and those to surgical and intensive care units (ICUs).
METHODS: Data were retrospectively collected from patients belonging to six referral hospitals in Italy between January 2011 and December 2013. Risk factors for 30-day mortality were evaluated in the whole patient population.
RESULTS: A total of 686 patients (mean age 70 ± 15 years) with candidemia were included. 367 (53.5 %) patients were in medicine wards, and 319 in surgery and ICUs. Host-related risk factors for candidemia were more common in medicine patients whereas healthcare-related factors in surgery/ICU patients. These patients showed severe sepsis and septic shock more commonly (71.7 %) than medicine patients (59.9 %) (p 0.003). The latter underwent central venous catheter (CVC) removal and adequate antifungal therapy less frequently than surgery/ICU patients. 149 (40.6 %) patients died with candidemia in medicine wards and 69 (21.6 %) in other wards (p < 0.001). Overall, the 30-day mortality was 36.3 %. At multivariate analysis, independent risk factors for death were aging, higher Charlson score, severe sepsis and septic shock, and no antifungal therapy, while major surgery and CVC removal were associated with higher probability of survival.
CONCLUSIONS: The burden of risk factors for candidemia was different between medicine patients and those in other wards. Despite the lower severity of candidemia in medicine patients, their mortality turned out to be higher than in surgery or ICU patients. Awareness of the best management of candidemia should be pursued, especially in medicine wards.

Entities:  

Keywords:  Candidemia; Elderly; Epidemiology; Medicine wards; Mortality; Risk factors

Mesh:

Year:  2016        PMID: 27401690     DOI: 10.1007/s15010-016-0924-9

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  33 in total

1.  Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility.

Authors:  M A Pfaller; D J Diekema
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

2.  Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain.

Authors:  M Puig-Asensio; B Padilla; J Garnacho-Montero; O Zaragoza; J M Aguado; R Zaragoza; M Montejo; P Muñoz; I Ruiz-Camps; M Cuenca-Estrella; B Almirante
Journal:  Clin Microbiol Infect       Date:  2013-10-11       Impact factor: 8.067

3.  Sentinel surveillance of invasive candidiasis in Spain: epidemiology and antifungal susceptibility.

Authors:  M C Nieto; O Tellería; R Cisterna
Journal:  Diagn Microbiol Infect Dis       Date:  2014-06-05       Impact factor: 2.803

4.  ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

Authors:  O A Cornely; M Bassetti; T Calandra; J Garbino; B J Kullberg; O Lortholary; W Meersseman; M Akova; M C Arendrup; S Arikan-Akdagli; J Bille; E Castagnola; M Cuenca-Estrella; J P Donnelly; A H Groll; R Herbrecht; W W Hope; H E Jensen; C Lass-Flörl; G Petrikkos; M D Richardson; E Roilides; P E Verweij; C Viscoli; A J Ullmann
Journal:  Clin Microbiol Infect       Date:  2012-12       Impact factor: 8.067

5.  Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000.

Authors:  M A Pfaller; D J Diekema; R N Jones; S A Messer; R J Hollis
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

Review 6.  Measuring the accuracy of diagnostic systems.

Authors:  J A Swets
Journal:  Science       Date:  1988-06-03       Impact factor: 47.728

7.  Epidemiology and outcome of nosocomial candidemia in elderly patients admitted prevalently in medical wards.

Authors:  Roberto Luzzati; Silvia Cavinato; Maria Luisa Deiana; Chiara Rosin; Cristina Maurel; Massimo Borelli
Journal:  Aging Clin Exp Res       Date:  2014-06-13       Impact factor: 3.636

8.  Comparison of results of fluconazole and voriconazole disk diffusion testing for Candida spp. with results from a central reference laboratory in the ARTEMIS DISK Global Antifungal Surveillance Program.

Authors:  Michael A Pfaller; Linda Boyken; Richard J Hollis; Jennifer Kroeger; Shawn A Messer; Shailesh Tendolkar; Daniel J Diekema
Journal:  Diagn Microbiol Infect Dis       Date:  2009-09       Impact factor: 2.803

9.  Initial antifungal strategy does not correlate with mortality in patients with candidemia.

Authors:  R Murri; G Scoppettuolo; G Ventura; M Fabbiani; F Giovannenze; F Taccari; E Milozzi; B Posteraro; M Sanguinetti; R Cauda; M Fantoni
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-12-03       Impact factor: 3.267

10.  The epidemiology, antifungal use and risk factors of death in elderly patients with candidemia: a multicentre retrospective study.

Authors:  Hao Wang; Naizheng Liu; Mei Yin; Hui Han; Jinfeng Yue; Fan Zhang; Tichao Shan; Haipeng Guo; Dawei Wu
Journal:  BMC Infect Dis       Date:  2014-11-25       Impact factor: 3.090

View more
  16 in total

1.  Epidemiological Trends of Fungemia in Greece with a Focus on Candidemia during the Recent Financial Crisis: a 10-Year Survey in a Tertiary Care Academic Hospital and Review of Literature.

Authors:  Maria Siopi; Aikaterini Tarpatzi; Eleni Kalogeropoulou; Sofia Damianidou; Alexandra Vasilakopoulou; Sophia Vourli; Spyros Pournaras; Joseph Meletiadis
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

2.  Molecular Analysis of Resistance and Detection of Non-Wild-Type Strains Using Etest Epidemiological Cutoff Values for Amphotericin B and Echinocandins for Bloodstream Candida Infections from a Tertiary Hospital in Qatar.

Authors:  Saad J Taj-Aldeen; Husam Salah; Winder B Perez; Muna Almaslamani; Mary Motyl; Atqah AbdulWahab; Kelley R Healey; David S Perlin
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

3.  A prediction rule for early recognition of patients with candidemia in Internal Medicine: results from an Italian, multicentric, case-control study.

Authors:  Emanuela Sozio; Filippo Pieralli; Anna Maria Azzini; Giancarlo Tintori; Federica Demma; Gianluca Furneri; Francesco Sbrana; Giacomo Bertolino; Simona Fortunato; Simone Meini; Damiano Bragantini; Alessandro Morettini; Carlo Nozzoli; Francesco Menichetti; Ercole Concia; Carlo Tascini
Journal:  Infection       Date:  2018-06-09       Impact factor: 3.553

4.  Personalized machine learning approach to predict candidemia in medical wards.

Authors:  Andrea Ripoli; Emanuela Sozio; Francesco Sbrana; Giacomo Bertolino; Carlo Pallotto; Gianluigi Cardinali; Simone Meini; Filippo Pieralli; Anna Maria Azzini; Ercole Concia; Bruno Viaggi; Carlo Tascini
Journal:  Infection       Date:  2020-08-01       Impact factor: 3.553

5.  Independent risk factors for mortality in critically ill patients with candidemia on Italian Internal Medicine Wards.

Authors:  Francesco Sbrana; Emanuela Sozio; Matteo Bassetti; Andrea Ripoli; Filippo Pieralli; Anna Maria Azzini; Alessandro Morettini; Carlo Nozzoli; Maria Merelli; Sebastiano Rizzardo; Giacomo Bertolino; Davide Carrara; Claudio Scarparo; Ercole Concia; Francesco Menichetti; Carlo Tascini
Journal:  Intern Emerg Med       Date:  2018-01-10       Impact factor: 3.397

6.  Candidemia in the elderly: What does it change?

Authors:  Francesco Barchiesi; Elena Orsetti; Sara Mazzanti; Francesca Trave; Aldo Salvi; Cinzia Nitti; Esther Manso
Journal:  PLoS One       Date:  2017-05-11       Impact factor: 3.240

7.  Antibodies against a β-glucan-protein complex of Candida albicans and its potential as indicator of protective immunity in candidemic patients.

Authors:  Antonella Torosantucci; Mario Tumbarello; Carla Bromuro; Paola Chiani; Brunella Posteraro; Maurizio Sanguinetti; Roberto Cauda; Antonio Cassone
Journal:  Sci Rep       Date:  2017-06-02       Impact factor: 4.379

8.  A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes.

Authors:  Lourdes Rodriguez; Beatriz Bustamante; Luz Huaroto; Cecilia Agurto; Ricardo Illescas; Rafael Ramirez; Alberto Diaz; Jose Hidalgo
Journal:  PLoS One       Date:  2017-04-18       Impact factor: 3.240

9.  Efficacy of introducing a checklist to reduce central venous line associated bloodstream infections in the ICU caring for adult patients.

Authors:  Dominic Wichmann; Cristina E Belmar Campos; Stephan Ehrhardt; Timo Kock; Claudia Weber; Holger Rohde; Stefan Kluge
Journal:  BMC Infect Dis       Date:  2018-06-08       Impact factor: 3.090

10.  Candidemia in non-ICU surgical wards: Comparison with medical wards.

Authors:  Antonio Vena; Emilio Bouza; Maricela Valerio; Belén Padilla; José Ramón Paño-Pardo; Mario Fernández-Ruiz; Ana Díaz Martín; Miguel Salavert; Alessandra Mularoni; Mireia Puig-Asensio; Patricia Muñoz
Journal:  PLoS One       Date:  2017-10-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.